Eli Lilly (LLY) shares outstanding

Shares outstanding · fiscal 2025
899.30M

Eli Lilly (LLY) had 899.30M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 0.5% lower than the 904.06M of fiscal 2024. Figures as of 17 Nov 2026, 17:17 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
899.30M
Change on fiscal 2024
−0.5%
Growth, 5 years
−0.3% a year
Growth, 10 years
−1.7% a year
Highest on record
1.12Bfiscal 2012
Lowest on record
899.30Mfiscal 2025
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Eli Lilly shares outstanding, in more detail

The market data feed counts 890.75M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count shrank at a compound 0.3% a year; over ten years the rate was −1.7% a year. Across the 18 fiscal years on record (2008–2025), the highest was 1.12B in fiscal 2012 and the lowest 899.30M in fiscal 2025.

History · 18 fiscal years

Shares outstanding by fiscal year

Eli Lilly shares outstanding, year by year

Eli Lilly (LLY) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025899.30M 0.5% down
2024904.06M 0.1% up
2023903.28M 4.9% down
2022950.18M 4.2% up
2021911.68M 0.1% down
2020912.51M 2.5% down
2019935.68M 9.5% down
20181.03B 1.7% down
20171.05B 0.9% down
20161.06B 0.4% down
20151.07B 0.8% down
20141.07B 1.0% down
20131.08B 2.9% down
20121.12B 0.3% up
20111.11B 0.7% up
20101.11B 0.7% up
20091.10B 0.4% up
20081.09B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Eli Lilly and comparable companies
CompanyShares outstandingFiscal year
Eli Lilly LLY899.30M2025
Johnson & Johnson JNJ2.43B2025
AbbVie ABBV1.77B2025
Merck & Co MRK2.51B2025
UnitedHealth Group UNH911.00M2025
Novartis NVS1.96B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on LLY

Eli Lilly, figure by figure

Eli Lilly (LLY) overview: price, valuation and scorecardAll health care companies by market value

Eli Lilly shares outstanding: questions and answers

How many shares does Eli Lilly have?

Eli Lilly (LLY) had 899.30M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 0.5% lower than the 904.06M of fiscal 2024. The market data feed counts 890.75M shares outstanding today.

What is the growth rate of Eli Lilly's diluted share count?

Over the five fiscal years to 2025 the diluted share count shrank at a compound 0.3% a year; over ten years the rate was −1.7% a year.

What are the highest and lowest diluted share count figures on record for Eli Lilly?

Across the 18 fiscal years on record (2008–2025), the highest was 1.12B in fiscal 2012 and the lowest 899.30M in fiscal 2025.

How is Eli Lilly's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Eli Lilly (LLY) shares outstanding”, data as of 17 November 2026. https://funkfolio.com/stock/LLY/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.